Non-inferiority and clinical superiority of glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors: systematic analysis of cardiorenal outcome trials in type 2 diabetes
Zaccardi F, Kloecker DE, Khunti K, Davies MJ
Diabetes Obes Metab. 2022;24(8):1598-1606.
Leggi